Embla Medical hf Stock: price and insider trades · Denmark
Embla Medical hf: what insiders have been doing
Only a handful of insider records exist for Embla Medical hf, the last one from 28 May 2018, too few to describe a trend. These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Embla Medical hf Buy (bullish), based on 5 analysts. Average price target: DKK 33.60.
Fundamental score
Ranked 13,480 of 26,914 companies
51.4
score / 100
Value40
Quality63
FCF yld0.9%
Earn yld0.7%
EV/EBITDA·
ROE11%
Gross mgn62%
Net mgn9.0%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
DKK 27.50
Analyst consensus
5 analystsBuy
DKK 30.00Target DKK 33.60(+22%)DKK 40.00
Income statement
RevenueDKK 928.7M
Gross profitDKK 578.6M62% margin
EBITDADKK 188.1M20% margin
Net incomeDKK 83.3M9.5% margin
Valuation
PER (trailing)19.5x
PER (forward)15.4x
P/Book1.9x
Beta0.46
Balance sheet & cash
Market capDKK 11.7B
Total debtDKK 541.6M
Free Cash FlowDKK 100.3M
Debt / Equity58%
Profitability & ownership
ROE10.7%
ROA4.9%
% insiders11.7%
% institutions78.8%
Last declaration on 28 May 2018
Declarations6 total
- ●Unknown0DK FSAShareISIN IS0000000040DK:842144
- ●Unknown0DK FSAShareISIN IS0000000040DK:814584
- ●Unknown0DK FSAShareDK:711511
- ●Unknown0DK FSAShareDK:298512
- ●Unknown0DK FSAShareDK:275564
- ●Unknown0DK FSAShareDK:275562
6 of 6 declarations
About Embla Medical hf
Embla Medical hf is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for the diagnosis and treatment of sleep disorders. It is listed on the XCSE exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
